Industrial Collaboration (new version)
Cancer Research KI strives to serve as a link facilitating interaction between Pharmaceutical companies and the cancer researchers at KI, with the aim of succesful longlasting collaborations.
In order for research findings to benefit society and patients there is a need for succesfull collaboration between the university, health care sector and industry. Cancer Research KI seeks to facilitate and promote collaboration with researchers in the cancer area at KI, and interacts with several Pharma
Industrial Collaboration Events
Industrial Profiles
Take a look at some of existing industrial collaborations in the cancer field
Industrial Collaboration Working Group
Contact Details of members of the working group
KI and Cancer Research Horizons Partnership
Karolinska Institutet and Cancer Research UK’s innovation engine, Cancer Research Horizons, have announced a 5-year strategic partnership dedicated to accelerating the translation of academic cancer research into improved treatments for patients. Under the terms of this new partnership, the parties have committed to several joint activities including research collaborations and funding initiatives, theme-based alliances, mutual access to facilities, expertise, materials, and tools, as well as joint events, and training programmes.
How to Establish Industrial Collaboration
A Workflow on how to move your project forward for industrial collaboration.
Corporate partnering
Cancer Research KI works closely with Richard Cowburn, Responsible for Corporate Partnering at KI, to strengthen and develop fruitful longterm collaborations in the cancer space between KI the pharma industry. These efforts will strengthen the ongoing collaboration between several individual research groups and companies, aim to give rise to new collaborations and allow for a more coordinated approach towards interaction with the industrial sector.
Commercialization of early discoveries
Karolinska Insitutet Innovations AB (KI Innovations) serves to support researchers at Karolinska Institutet in getting their research results developed to commercial products for the benefit of patients and society. Cancer Research KI works closely with KI Innovations and you are most welcome to turn to them with any questions you might have consering commercialization of your research ideas and results - no question is too small and it is never too early to approach them for a first discussion. Conatct person for cancer at KI Innovation is Mats Ferm.